Computational and Structural Biotechnology Journal

Global Hypomethylation in Cell-Free DNA Enables Noninvasive Colorectal Cancer Screening: Results from a Retrospective Validation Study

Fig. 1. Performance of Asima Rev evaluated in patients with colorectal cancer (CRC) (n = 46) and healthy individuals (n = 33).
Open the figure at full size
Fig. 1. Performance of Asima Rev evaluated in patients with colorectal cancer (CRC) (n = 46) and healthy individuals (n = 33).Performance of Asima Rev evaluated in patients with colorectal cancer (CRC) (n = 46) and healthy individuals (n = 33).Kaur et al.
Case-control study in peopleBiomarkers

The paper

Asima Health Inc

Computational and Structural Biotechnology Journal, 28 Aug 2026

doi.org/10.34133/csbj.0181PubMed 42666404